Standard

Versatile Diazomethane Sulfonamide for Expedited Exploration of Azole‐Based Carbonic Anhydrase Inhibitors via [3+2] Cycloaddition. / Krivovicheva, Vasilisa; Bubyrev, Andrey; Kalinin, Stanislav; Dar'in, Dmitry; Gureev, Maxim; Burianova, Valeria; Vullo, Daniella; Krasavin, Mikhail; Supuran, Claudiu T.

In: Farmaco, Vol. 18, No. 10, e202200607, 12.04.2023.

Research output: Contribution to journal › Article › peer-review

Harvard

Krivovicheva, V, Bubyrev, A, Kalinin, S, Dar'in, D, Gureev, M, Burianova, V, Vullo, D, Krasavin, M & Supuran, CT 2023, 'Versatile Diazomethane Sulfonamide for Expedited Exploration of Azole‐Based Carbonic Anhydrase Inhibitors via [3+2] Cycloaddition', Farmaco, vol. 18, no. 10, e202200607. https://doi.org/10.1002/cmdc.202200607, https://doi.org/10.1002/cmdc.202200607

APA

Krivovicheva, V., Bubyrev, A., Kalinin, S., Dar'in, D., Gureev, M., Burianova, V., Vullo, D., Krasavin, M., & Supuran, C. T. (2023). Versatile Diazomethane Sulfonamide for Expedited Exploration of Azole‐Based Carbonic Anhydrase Inhibitors via [3+2] Cycloaddition. Farmaco, 18(10), [e202200607]. https://doi.org/10.1002/cmdc.202200607, https://doi.org/10.1002/cmdc.202200607

Vancouver

Krivovicheva V, Bubyrev A, Kalinin S, Dar'in D, Gureev M, Burianova V et al. Versatile Diazomethane Sulfonamide for Expedited Exploration of Azole‐Based Carbonic Anhydrase Inhibitors via [3+2] Cycloaddition. Farmaco. 2023 Apr 12;18(10). e202200607. https://doi.org/10.1002/cmdc.202200607, https://doi.org/10.1002/cmdc.202200607

Author

Krivovicheva, Vasilisa ; Bubyrev, Andrey ; Kalinin, Stanislav ; Dar'in, Dmitry ; Gureev, Maxim ; Burianova, Valeria ; Vullo, Daniella ; Krasavin, Mikhail ; Supuran, Claudiu T. / Versatile Diazomethane Sulfonamide for Expedited Exploration of Azole‐Based Carbonic Anhydrase Inhibitors via [3+2] Cycloaddition. In: Farmaco. 2023 ; Vol. 18, No. 10.

BibTeX

@article{70ab72de20e2411f8ff87c467a8d525a,
title = "Versatile Diazomethane Sulfonamide for Expedited Exploration of Azole‐Based Carbonic Anhydrase Inhibitors via [3+2] Cycloaddition",
abstract = "A newly introduced diazo reagent enables access to a range of azole-based primary sulfonamides highly relevant in the context of inhibition of therapeutically valuable isoforms of carbonic anhydrase. This new synthetic strategy will support the discovery of novel, isoform-selective inhibitors of carbonic anhydrase within the poorly explored azole chemical space.",
keywords = "C−H diazomethane sulfonamide, [3+2] dipolar cycloaddition, carbonic anhydrase, isoform selectivity, p-methoxybenzyl protecting group, primary sulfonamide",
author = "Vasilisa Krivovicheva and Andrey Bubyrev and Stanislav Kalinin and Dmitry Dar'in and Maxim Gureev and Valeria Burianova and Daniella Vullo and Mikhail Krasavin and Supuran, {Claudiu T.}",
year = "2023",
month = apr,
day = "12",
doi = "10.1002/cmdc.202200607",
language = "English",
volume = "18",
journal = "Farmaco",
issn = "1860-7179",
publisher = "Wiley-Blackwell",
number = "10",

}

RIS

TY - JOUR

T1 - Versatile Diazomethane Sulfonamide for Expedited Exploration of Azole‐Based Carbonic Anhydrase Inhibitors via [3+2] Cycloaddition

AU - Krivovicheva, Vasilisa

AU - Bubyrev, Andrey

AU - Kalinin, Stanislav

AU - Dar'in, Dmitry

AU - Gureev, Maxim

AU - Burianova, Valeria

AU - Vullo, Daniella

AU - Krasavin, Mikhail

AU - Supuran, Claudiu T.

PY - 2023/4/12

Y1 - 2023/4/12

N2 - A newly introduced diazo reagent enables access to a range of azole-based primary sulfonamides highly relevant in the context of inhibition of therapeutically valuable isoforms of carbonic anhydrase. This new synthetic strategy will support the discovery of novel, isoform-selective inhibitors of carbonic anhydrase within the poorly explored azole chemical space.

AB - A newly introduced diazo reagent enables access to a range of azole-based primary sulfonamides highly relevant in the context of inhibition of therapeutically valuable isoforms of carbonic anhydrase. This new synthetic strategy will support the discovery of novel, isoform-selective inhibitors of carbonic anhydrase within the poorly explored azole chemical space.

KW - C−H diazomethane sulfonamide

KW - [3+2] dipolar cycloaddition

KW - carbonic anhydrase

KW - isoform selectivity

KW - p-methoxybenzyl protecting group

KW - primary sulfonamide

UR - https://www.mendeley.com/catalogue/ced44048-dc24-3877-ae72-4487184a5aed/

U2 - 10.1002/cmdc.202200607

DO - 10.1002/cmdc.202200607

M3 - Article

VL - 18

JO - Farmaco

JF - Farmaco

SN - 1860-7179

IS - 10

M1 - e202200607

ER -

ID: 113685742